Page 72 - 南京医科大学学报自然科学版
P. 72
第42卷第10期
·1414 · 南 京 医 科 大 学 学 报 2022年10月
cet Diabetes Endocrinol,2019,7(6):429-441 with sodium⁃glucose co⁃transporter⁃2 inhibitors[J]. Dia⁃
[9] HERNANDEZ M,SULLIVAN R D,MCCUNE M E,et al. betes Obes Metab,2021,23(9):2077-2089
Sodium⁃glucose cotransporter⁃2 inhibitors improve heart [20] CAPOLONGO G,CAPASSO G,VIGGIANO D. A shared
failure with reduced ejection fraction outcomes by reduc⁃ nephroprotective mechanism for renin⁃angiotensin⁃system
ing edema and congestion[J]. Diagnostics(Basel),2022, inhibitors,sodium ⁃ glucose co ⁃ transporter 2 inhibitors,
12(4):989 and vasopressin receptor antagonists:immunology meets
[10] 胡 健,李 英,王晓琴. 六种肾小球滤过率估算公式 hemodynamics[J]. Int J Mol Sci,2022,23(7):3915
用于多发性骨髓瘤患者肾功能评估的一致性分析[J]. [21] XUAN M Y,PIAO S G,DING J,et al. Dapagliflozin alle⁃
山西医科大学学报,2019,50(10):1364-1373 viates renal fibrosis by inhibiting RIP1⁃RIP3⁃MLKL⁃me⁃
[11] KINGUCHI S,WAKUI H,ITO Y,et al. Improved home diated necroinflammation in unilateral ureteral obstruction
BP profile with dapagliflozin is associated with ameliora⁃ [J]. Front Pharmacol,2021,12:798381
tion of albuminuria in Japanese patients with diabetic ne⁃ [22] ELKAZZAZ S K,KHODEER D M,EL FAYOUMI H M,
phropathy:the Yokohama add ⁃ on inhibitory efficacy of et al. Role of sodium glucose cotransporter type 2 inhibi⁃
dapagliflozin on albuminuria in Japanese patients with tors dapagliflozin on diabetic nephropathy in rats:inflam⁃
type 2 diabetes study(Y⁃AIDA study)[J]. Cardiovasc Di⁃ mation,angiogenesis and apoptosis[J]. Life Sci,2021,
abetol,2019,18(1):110 280:119018
+
+
[12] KAWABATA N,OKADA K,ANDO A,et al. Comparison [23] ZHUANG R,MENG Q,MA X,et al. CD4 FoxP3 CD73 +
of the effects of frequent versus conventional nutritional regulatory T cell promotes cardiac healing post⁃myocardi⁃
interventions in patients with type 2 diabetes mellitus:a al infarction[J]. Theranostics,2022,12(6):2707-2721
randomized,controlled trial[J]. J Diabetes Investig, [24] HU M,ROGERS N M,LI J,et al. Antigen specific regula⁃
2022,13(2):271-279 tory T cells in kidney transplantation and other tolerance
[13] DEFRONZO R A,REEVES W B,AWAD A S. Pathophys⁃ settings[J]. Front Immunol,2021,12:717594
iology of diabetic kidney disease:impact of SGLT2 inhibi⁃ [25] ALI R,PATEL S,HUSSAIN T. Angiotensin type 2 recep⁃
tors[J]. Nat Rev Nephrol,2021,17(5):319-334 tor activation limits kidney injury during the early phase
[14] RAM C,JHA A,GHOSH A,et al. Targeting NLRP3 in⁃ and induces Treg cells during the late phase of renal isch⁃
flammasome as a promising approach for treatment of dia⁃ emia[J]. Am J Physiol Renal Physiol,2021,320(5):
betic nephropathy:preclinical evidences with therapeutic F814-F825
approaches[J]. Eur J Pharmacol,2020,885:173503 [26] SONG J,XIA Y,YAN X,et al. Losartan accelerates the
[15] WIVIOTT S D,RAZ I,BONACA M P,et al. Dapagliflozin repair process of renal fibrosis in UUO mouse after the
and cardiovascular outcomes in type 2 diabetes[J]. N surgical recanalization by upregulating the expression of
Engl J Med,2019,380(4):347-357 Tregs[J]. Int Urol Nephrol,2019,51(11):2073-2081
[16] PERKOVIC V,JARDINE M J,NEAL B,et al. Cana⁃ [27] KONG L,ANDRIKOPOULOS S,MACISAAC R J,et al.
gliflozin and renal outcomes in type 2 diabetes and ne⁃ Role of the adaptive immune system in diabetic kidney
phropathy[J]. N Engl J Med,2019,380(24):2295-2306 disease[J]. J Diabetes Investig,2022,13(2):213-226
[17] 阳 皓,谭巧灵,王 岑,等. 达格列净对早期2型糖尿 [28] 褚 璇,赵 猛,孙 娟,等. 2 型糖尿病患者外周血 T
病肾病患者尿微量白蛋白和促炎症因子的影响[J]. 华 淋巴细胞亚群表达与糖尿病肾脏疾病关系的研究[J].
中科技大学学报(医学版),2019,48(4):400-404 中国糖尿病杂志,2021,29(12):902-906
[18] NEUEN B L,OSHIMA M,AGARWAL R,et al. Sodium⁃ [29] WANG D,ZHANG Z,SI Z,et al. Dapagliflozin reverses
glucose cotransporter 2 inhibitors and risk of hyperkale⁃ the imbalance of T helper 17 and T regulatory cells by in⁃
mia in people with type 2 diabetes:a Meta⁃analysis of in⁃ hibiting SGK1 in a mouse model of diabetic kidney dis⁃
dividual participant data from randomized,controlled tri⁃ ease[J]. FEBS Open Bio,2021,11(5):1395-1405
als[J]. Circulation,2022,145(19):1460-1470 [30] 魏 晗,辛小军,王 曼,等. SGLT⁃2 抑制剂改善糖尿
[19] CHAN Y,CHEN S,CHAO T,et al. Impact of the initial 病患者心血管疾病预后的研究进展[J]. 南京医科大学
decline in estimated glomerular filtration rate on the risk 学报(自然科学版),2020,40(5):773-778
of new⁃onset atrial fibrillation and adverse cardiovascular [收稿日期] 2022-04-20
and renal events in patients with type 2 diabetes treated (责任编辑:蒋 莉)